Search

Regulating Harmful Contaminants for Healthier Communities

BACKGROUND

Protections against toxic substances

We encounter countless toxic substances without even realizing it—in indoor air, drinking water, contaminated dust, consumer products, older homes and buildings, and workplace activities such as manufacturing, processing, cleaning, maintenance, and disposal. Their risks to humans are often well known, but many harmful substances remain unregulated. 

Through the Toxic Substances Control Act (TSCA), enacted in 1976 and strengthened in 2016, the U.S. Environmental Protection Agency (EPA) has the authority to review and regulate the production, import, use, and disposal of unsafe chemicals. 

For more than 30 years, Abt has helped EPA’s Office of Pollution Prevention and Toxics (OPPT) turn complex chemical-safety statutes into workable regulations and implementation tools. Across more than 100 OPPT regulatory actions — including nearly 70 in the past five years — Abt has provided economic and regulatory analysis, modeling, stakeholder engagement, rulemaking support, and technical assistance for implementation, outreach, and training.

WHAT WE’RE DOING

Regulatory processes to protect communities and environments

Our environmental team has helped the EPA advance several landmark regulatory efforts that will improve safety for millions of people and reduce workplace chemical exposures for tens of thousands more. This included finalizing rules for several toxic substances, including asbestos, carbon tetrachloride (CTC), methylene chloride, perchloroethylene (PCE), trichlorethylene (TCE), and dust lead.

Working with multiple EPA offices, Abt combined health, data science, research, and technical expertise to support each stage of the regulatory process, including risk evaluation, economic analysis, rule drafting, and response to public input. We structured analyses to align with federal guidance and support transparent, defensible decisions. 

Years in the making, these new rules will reduce risks of cancer, developmental disorders, and heart disease for people exposed.

Let’s zero in on carbon tetrachloride (CTC), used in petrochemical and industrial settings. Under TSCA, EPA identified CTC as a human carcinogen linked to liver cancer, brain tumors, and adrenal gland tumors while also contributing to ozone depletion. This multifaceted threat triggered the need for regulatory action. 

Abt supported EPA’s development of the 2024 CTC rule by providing economic and sensitivity analyses that informed regulatory options and understanding of how the rule would affect industry, workers, and the public. This analysis informed EPA’s approach to ban non-essential uses, set strict controls for critical exempted uses, and require monitoring and reporting to support implementation and oversight. In practice, our role was to translate scientific findings into regulatory decisions grounded in cost, impact, and feasibility.
 

IMPACT

Rigorous analysis undergirds rulemaking

The final CTC rule, published in December 2024, turns a known toxic hazard into enforceable protections. It will reduce exposure for tens of thousands of workers in facilities where CTC is still used, strengthen protections over time for communities located near those facilities, and limit environmental harm by reducing contributions to ozone depletion. The rule shows how rigorous analysis can support stronger toxic substance regulation for measurable public health and community benefits.

Abt analyses supported EPA in quantifying and monetizing benefits for occupational users and non-users, while noting that additional cancer, non-cancer, dermal-exposure, and environmental benefits are real but difficult to measure. This strengthens the regulatory record and supports transparent decision-making. 
 

WHY THIS MATTERS

Landmark rules that protect health and safety

The CTC rule and other regulations show how strong data and regulatory analyses translate into measurable public health and environmental benefits. Backed by Abt’s rigorous research, these rules are a significant victory in protecting families, American workers, and the environment—closing critical regulatory gaps on some of the most harmful substances in circulation. 


Project

Multiple

Client

U.S. Environmental Protection Agency (EPA), Office of Pollution Prevention and Toxics (OPPT)

 

Featured in our 2026 Mission Impact Report

Read More

Health

Abt at the Potomac Officers Club 2026 Healthcare Summit

Abt Global, Lead Platinum Sponsor of the POC 2026 Healthcare Summit, joins federal health leaders on AI, data, and access and hosts an AI governance panel.

Learn More
Event

New England Rural Health Association Conference 2026

Abt evaluator Julia Higgins presents RCORP findings for grantees based in rural New England at the NERHA 2026 Annual Conference, Nov. 18 in Concord, NH.

Learn More
Event

Making Data Meaningful: The Power of Data Storytelling in CMS Rural Health Transformation Programs

Discover how data storytelling can help states communicate the impact of CMS Rural Health Transformation Programs, demonstrate results, and sustain investments.

Learn More
Blog

National Association of Medicaid Directors (NAMD) Fall Conference 2026

Abt Global is a Sapphire sponsor of the NAMD 2026 Fall Conference. Find our Medicaid policy and data team at Booth 122.

Learn More
Event

Medicaid Section 1115 Reentry: What 19 State Demonstrations Reveal About Expanding Access to Care

Abt conducted an environmental scan of CMS-approved Medicaid reentry demonstrations, comparing how states are designing their programs and navigating different correctional settings.

Learn More
Publication

Stronghold Federal MPJV Awarded GSA MAS

Stronghold Federal’s GSA MAS award gives agencies streamlined access to IT modernization, data, and systems integration services.

Learn More
News

Beyond the Red Flag: A Smarter Approach to Medicaid Program Integrity

How explainable, human-guided AI can help Medicaid programs focus on meaningful fraud signals, reduce noise, and act earlier.

Learn More
Blog

Evaluating SMART Recovery in Active-Duty Service Members

Abt is testing whether the SMART Recovery program can reduce risky drinking and support military readiness.

Learn More
Project
Lisa Simeon: Veterans, Your Mission Continues

Lisa Simeon: Veterans, Your Mission Continues

Learn More
Video
Kathleen Flanagan: Military Mindset, Visionary Founder

Kathleen Flanagan: Military Mindset, Visionary Founder

Learn More
Video

Advancing Whole-Person Health: Implementing and Monitoring the MAHA ELEVATE Model

Abt supports CMS in implementing and monitoring the MAHA ELEVATE Model to build evidence on functional and lifestyle medicine approaches to manage and improve chronic disease for Original Medicare beneficiaries.

Learn More
Project